Baicheng Pharmaceutical announced that BIOS2220 has obtained a clinical trial approval notice.
百诚医药：BIOS2220获得临床试验批准通知书
Baicheng Pharmaceutical: BIOS2220 Receives Clinical Trial Approval Notice
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.